The Spectrum of Epidermolysis Bullosa in KwaZulu‐Natal, South Africa
JEB, with a recurrent pathogenic variant in LAMB3, emerged as the predominant subtype among African Zulu patients, underscoring the critical need for early diagnosis and tailored management strategies in resource-limited settings. Integrating clinicopathological and genetic data is essential for accurate diagnosis and prognosis, emphasizing the importance of advanced diagnostic tools in improving outcomes for EB patients in South Africa.
Authors
- Hui‐Ching Cheng (ORCID: https://orcid.org/0000-0002-4732-602X)
- Thirona Naicker (ORCID: https://orcid.org/0000-0001-7146-7159)
- Chao‐Kai Hsu (ORCID: https://orcid.org/0000-0003-4365-4533)
- Ncoza Cordelia Dlova (ORCID: https://orcid.org/0000-0002-2425-3905)
- Cassandra Bruce‐Brand (ORCID: https://orcid.org/0000-0003-0438-768X)
- Colleen Aldous (ORCID: https://orcid.org/0000-0002-7199-9160)
- Antoinette Chateau (ORCID: https://orcid.org/0000-0001-9825-6191)
- Hsin‐Yu Huang (ORCID: https://orcid.org/0000-0002-7320-5870)
- John A. McGrath (ORCID: https://orcid.org/0000-0002-3708-9964)
- J Schneider (ORCID: https://orcid.org/0000-0001-5187-6756)
- P. W. Lin
Institutions
- National Health Laboratory Service (ZA)
- King's College London (GB)
- Stellenbosch University (ZA)
- Tygerberg Hospital (ZA)
- Grey's Hospital (ZA)
- National Cheng Kung University Hospital (TW)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1111/ijd.17843
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Inyuvesi Yakwazulu-Natali